Use of Angiotensin Receptor Blockers in Combination Therapy of Patients with Essential Hypertension and Diabetes Mellitus

Abstract

The article describes a group of drugs used for comorbidity, the comparative characterization of angiotensin II receptor blockers (ARB) and angiotensin-converting enzyme (ACE) inhibitors, listed on the efficacy and safety data from a representative group of ARBs – azilsartan, presented the results clinical studies on these issues.

Keywords

• chronic kidney disease
• diabetes mellitus
• hypertension
• angiotensin II receptor blockers
• angiotensin-converting enzyme inhibitors
• azilsartan medoxomil